Stereotaxis Share Price (NYSE: STXS)

$2.87

▲

0.06

(2.14%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Stereotaxis Stock chart to analyse performance

Stereotaxis stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$2.84
Today's High:$2.92
$2.87
1.05%
Downside
Day's Volatility :2.57%
Upside
1.54%
52 Weeks Low:$1.54
52 Weeks High:$3.05
$2.87
46.34%
Downside
52 Weeks Volatility :49.52%
Upside
5.93%

Stereotaxis Stock Returns

Period	Stereotaxis Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	28.92%	3.6%	0.0%
6 Months	48.2%	-7.7%	0.0%
1 Year	28.35%	-12.6%	0.0%
3 Years	38.89%	9.5%	-4.7%

Stereotaxis Inc Key Stats

Check Stereotaxis key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$2.81
Open	$2.9
Today's High	$2.915
Today's Low	$2.84
Market Capitalization	$260.2M
Today's Volume	$305.6K
52 Week High	$3.051
52 Week Low	$1.54
Revenue TTM	$31.8M
EBITDA	$-20.2M
Earnings Per Share (EPS)	$-0.29
Profit Margin	-73.43%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-198.62%

Stock Returns calculator for Stereotaxis Stock including INR - Dollar returns

The Stereotaxis stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Stereotaxis investment value today

Current value as on today

₹1,33,409

Returns

₹33,409

(+33.41%)

Returns from Stereotaxis Stock

₹28,125 (+28.12%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Stereotaxis Stock

-29%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Stereotaxis Stock from India on INDmoney has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Stereotaxis Stock

Rating

Trend

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Stereotaxis(by analysts ranked 0 to 5 stars)

Stereotaxis Share Price Target

What analysts predicted

Upside of 56.79%

Target:

$4.50

Current:

$2.87

Stereotaxis share price target is $4.50, a slight Upside of 56.79% compared to current price of $2.87 as per analysts' prediction.

Stereotaxis Stock Insights

Price Movement
In the last 1 month, STXS stock has moved up by 19.8%
Increasing Revenue
Revenue is up for the last 3 quarters, 6.34M → 8.79M (in $), with an average increase of 15.1% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -7.51M → -3.82M (in $), with an average increase of 40.6% per quarter

Stereotaxis Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$28.9M	↓ 1.51%
Net Income	$-4.2M	↓ 3725.49%
Net Profit Margin	-14.65%	↓ 15.05%

	FY20	Y/Y Change
Revenue	$26.6M	↓ 7.86%
Net Income	$-6.5M	↑ 52.44%
Net Profit Margin	-24.23%	↓ 9.58%

	FY21	Y/Y Change
Revenue	$35.0M	↑ 31.51%
Net Income	$-10.7M	↑ 66.07%
Net Profit Margin	-30.6%	↓ 6.37%

	FY22	Y/Y Change
Revenue	$28.1M	↓ 19.63%
Net Income	$-19.2M	↑ 78.71%
Net Profit Margin	-68.04%	↓ 37.44%

	FY23	Y/Y Change
Revenue	$26.8M	↓ 4.89%
Net Income	$-20.7M	↑ 8.16%
Net Profit Margin	-77.37%	↓ 9.33%

	FY24	Y/Y Change
Revenue	$26.9M	↑ 0.55%
Net Income	$-24.0M	↑ 16.09%
Net Profit Margin	-89.33%	↓ 11.96%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$6.9M	↑ 50.71%
Net Income	$-4.5M	↓ 10.58%
Net Profit Margin	-65.51%	↑ 44.9%

	Q2 FY24	Q/Q Change
Revenue	$4.5M	↓ 34.56%
Net Income	$-5.8M	↑ 29.42%
Net Profit Margin	-129.56%	↓ 64.05%

	Q3 FY24	Q/Q Change
Revenue	$9.2M	↑ 104.26%
Net Income	$-6.2M	↑ 6.12%
Net Profit Margin	-67.31%	↑ 62.25%

	Q4 FY24	Q/Q Change
Revenue	$6.3M	↓ 31.06%
Net Income	$-7.5M	↑ 21.41%
Net Profit Margin	-118.53%	↓ 51.22%

	Q1 FY25	Q/Q Change
Revenue	$7.5M	↑ 17.85%
Net Income	$-5.8M	↓ 22.51%
Net Profit Margin	-77.93%	↑ 40.6%

	Q2 FY25	Q/Q Change
Revenue	$8.8M	↑ 17.75%
Net Income	$-3.8M	↓ 34.3%
Net Profit Margin	-43.49%	↑ 34.44%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$22.8M	↓ 3.65%

	FY20	Y/Y Change
Profit	$19.0M	↓ 16.69%

	FY21	Y/Y Change
Profit	$23.2M	↑ 22.49%

	FY22	Y/Y Change
Profit	$18.5M	↓ 20.5%

	FY23	Y/Y Change
Profit	$14.9M	↓ 19.55%

	FY24	Y/Y Change
Profit	$14.6M	↓ 1.79%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$4.0M	↑ 44.85%

	Q2 FY24	Q/Q Change
Profit	$3.3M	↓ 16.46%

	Q3 FY24	Q/Q Change
Profit	$4.1M	↑ 23.72%

	Q4 FY24	Q/Q Change
Profit	$3.2M	↓ 21.54%

	Q1 FY25	Q/Q Change
Profit	$4.1M	↑ 26.37%

	Q2 FY25	Q/Q Change
Profit	$4.6M	↑ 12.67%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-4.6M	↑ 81.29%
Investing Cash Flow	$-29.5K	↓ 88.89%
Financing Cash Flow	$24.0M	↑ 142.22%

	FY20	Y/Y Change
Operating Cash Flow	$-3.5M	↓ 23.93%
Investing Cash Flow	$-70.9K	↑ 140.44%
Financing Cash Flow	$17.3M	↓ 27.85%

	FY21	Y/Y Change
Operating Cash Flow	$-2.9M	↓ 16.11%
Investing Cash Flow	$-1.4M	↑ 1869.91%
Financing Cash Flow	$547.4K	↓ 96.84%

	FY22	Y/Y Change
Operating Cash Flow	$-8.4M	↑ 185.65%
Investing Cash Flow	$-22.1M	↑ 1482.0%
Financing Cash Flow	$220.0K	↓ 59.81%

	FY23	Y/Y Change
Operating Cash Flow	$-9.1M	↑ 8.6%
Investing Cash Flow	$19.8M	↓ 189.46%
Financing Cash Flow	$81.0K	↓ 63.18%

	FY24	Y/Y Change
Operating Cash Flow	$-8.5M	↓ 7.02%
Investing Cash Flow	$74.0K	↓ 99.63%
Financing Cash Flow	$297.0K	↑ 266.67%

Q2 FY24

Q3 FY24

Q4 FY24

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-3.1M	↑ 31.63%
Investing Cash Flow	$-22.0K	-
Financing Cash Flow	$28.0K	↓ 6.67%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-4.3M	↑ 40.19%
Investing Cash Flow	$98.0K	↓ 545.45%
Financing Cash Flow	$80.0K	↑ 185.71%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$1.3M	↓ 129.24%
Investing Cash Flow	$-2.0K	↓ 102.04%
Financing Cash Flow	$159.0K	↑ 98.75%

Stereotaxis Technicals Summary

Sell

Neutral

Buy

Stereotaxis is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Stereotaxis Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Stereotaxis Inc	29.5%	48.2%	28.35%	38.89%	-19.01%
Intuitive Surgical, Inc.	-2.14%	-16.61%	-2.2%	129.39%	91.27%
Alcon Ag	-9.17%	-15.22%	-16.6%	20.12%	40.07%
West Pharmaceutical Services Inc	3.24%	8.32%	-18.78%	-16.58%	-12.33%
Resmed Inc.	-1.56%	17.91%	12.23%	25.22%	53.62%
Becton, Dickinson And Company	9.36%	-15.57%	-20.36%	-24.43%	-19.91%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Stereotaxis Inc	NA	NA	0.0	-0.23	-1.99	-0.35	NA	0.02
Intuitive Surgical, Inc.	66.27	66.27	3.47	8.14	0.16	0.09	NA	49.79
Alcon Ag	36.78	36.78	2.16	3.1	0.05	0.03	0.0	44.73
West Pharmaceutical Services Inc	36.74	36.74	3.55	6.76	0.18	0.11	0.0	40.74
Resmed Inc.	28.99	28.99	1.9	9.5	0.26	0.14	0.01	40.77
Becton, Dickinson And Company	35.34	35.34	0.96	14.37	0.06	0.04	0.02	88.87

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Stereotaxis Inc	Buy	$260.2M	-19.01%	NA	-73.43%
Intuitive Surgical, Inc.	Buy	$169.9B	91.27%	66.27	28.51%
Alcon Ag	Buy	$39.3B	40.07%	36.78	10.7%
West Pharmaceutical Services Inc	Buy	$17.7B	-12.33%	36.74	16.48%
Resmed Inc.	Buy	$40.3B	53.62%	28.99	27.22%
Becton, Dickinson And Company	Buy	$55.3B	-19.91%	35.34	7.41%

About Stereotaxis Inc

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is designed to enhance the accessibility of RMN by eliminating the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; V-CAS; and MAGiC catheter for cardiac ablation procedures. Further, it provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Organization	Stereotaxis
Employees	139
CEO	Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.
Industry	Medical Specialties

Key Management of Stereotaxis Inc

Name	Title
Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.	CEO & Chairman
Mr. Keith Galloway	Vice President of Operations
Ms. Patricia S. Williams Esq.	General Counsel & Secretary

Important FAQs about investing in STXS Stock from India :

What is Stereotaxis share price today?

Stereotaxis share price today is $2.87 as on August 30, 2025 at 1:29 am IST at the close of the market. Stereotaxis share today touched a day high of $2.92 and a low of $2.84.

What is the 52 week high and 52 week low for Stereotaxis share?

Stereotaxis share touched a 52 week high of $3.05 and a 52 week low of $1.54. Stereotaxis stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $2.87, lower by 5.93% versus the 52 week high.

How to invest in Stereotaxis Stock (STXS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Stereotaxis on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Stereotaxis Shares that will get you 0.5226 shares as per Stereotaxis share price of $2.87 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Stereotaxis Stock (STXS) from India?

Indian investors can start investing in Stereotaxis (STXS) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Stereotaxis stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Stereotaxis share’s latest price of $2.87 as on August 30, 2025 at 1:29 am IST, you will get 3.4843 shares of Stereotaxis. Learn more about fractional shares .

What are the returns that Stereotaxis has given to Indian investors in the last 5 years?

Stereotaxis stock has given -19.01% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?